欧美成在线 I 色吧伊人 I 亚洲综合国产成人无码 I 欧美最新在线 I 国内少妇偷人精品视频 I 人人插人人 I 综合一区在线 I 欧美一二三级 I 欧美视频一区在线观看 I 成年无码av片在线狼人 I av片一区 I 日本老熟妇乱 I 人人看人人澡 I 日韩av免费无码一区二区三区 I 善良的妈妈在线播放 I 唯美欧美亚洲 I 免费看的黄色网址 I 老头吃奶性行交视频 I 国产激情三区 I 亚洲成av人片无码迅雷下载 I 欧美大屁股流白浆xxxx I 四虎官网 I 日本高清www I 国产精品久久嫩一区二区免费 I 亚洲乱亚洲乱妇在线观看 I 波多野结衣黄 I 欧美丰满熟妇xxxx性多毛 I 在线免费播放毛片 I 中国精品偷拍区偷拍无码 I 久久人人av I 亚洲精品色婷婷在线影院 I 粉嫩av中文字幕 I 一区二区三区四区五区视频在线观看 I 国产丝袜在线播放 I 顶级嫩模被啪啪得娇喘呻吟

一.產品名稱：

通用名稱：大/小鼠成纖維細胞生長因子23 ELISA試劑盒

英文名稱：Mouse/Rat FGF-23 ELISA Kit

二.Mouse FGF-23 ELISA介紹：

Mouse/Rat FGF-23 ELISA Kit is intended for research use only in the quantitative determination of Mouse FGF-23 levels in serum, plasma or cell culture media. This assay is also useful in the determination of Rat FGF-23 levels.
 

Fibroblast growth factor 23 (FGF-23) is a recently discovered, novel member of a large family of related proteins. Its gene encodes a 251 amino acid protein. The amino-terminal portion of FGF-23 (aa 1-24) is hydrophobic and is likely to serve as a signal peptide allowing its secretion into the blood circulation. Its carboxyl-terminal portion (aa 180-251) shares only limited amino acid homology with other members of the FGF family of proteins.

Renal phosphate wasting disorders leading to hypophosphatemia are among the causes of defective mineralization of bone and growth plate development. Autosomal dominant hypophosphatemic rickets (ADHR), a rare genetic disorder, results from one of several different FGF-23 mutations that make the protein resistant to proteolytic cleavage. Furthermore, tumors that cause oncogenic osteomalacia (OOM) have been shown to overexpress FGF-23 mRNA making it likely that elevated concentrations of FGF-23 in the blood are the cause of renal phosphate wasting. Consistent with this conclusion, the administration of recombinant FGF-23 to rodents was shown to increase urinary excretion of phosphate thus leading to hypophosphatemia and osteomalacia/rickets. Recent studies with chronic kidney disease (CKD) patients have shown FGF-23 to be an early predictor of abnormal renal tubular function, bone mineralization, disease progression and over-all mortality risk.

Taken together, all currently available data suggest that the measurement of FGF-23 levels may provide an important diagnostic tool for the evaluation of hypophosphatemic and hyperphosphatemic disorders.
 

如需了解更多產品，請北京科瑞美公司。